Skip to content

Federal Contractor Profile

Lovelace Biomedical Research Institute

$137M obligated·169 awards·6 agencies·14 NAICS

Federal Contracts

Showing award actions 1–50 of 209 funded award actions, most recent first.

Contracts with positive obligations
169
Funded award actions shown
209
Obligations shown
$137M
Awarding agencies
6

This table shows award actions with a positive obligation. Zero-dollar and negative-dollar actions, such as administrative changes and deobligations, are not displayed. Multiple award actions may belong to the same contract.

Award data as of November 5, 2026. Source: USAspending federal award records.

DateAgencyPIIDNAICSDescriptionAmount
Sep 25, 2026Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO75N98026F00001541714GLP REPEAT DOSE TOXICOLOGY STUDY FOR A LIVE-ATTENUATED RESPIRATORY VIRUS VACCINE.$340K
Sep 14, 2026Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS75F40126F19003541690NICOTINE FLUX: INVESTIGATING THE IMPACT OF ENDS OUTPUT POWER AND HEATING ELEMENT ON ABUSE LIABILITY$3.0M
Aug 21, 2026Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA75A50126F61002541714RTOR BIO-AMT-2312: ASSESSMENT OF THE THERAPEUTIC POTENTIAL OF CHLOROQUINE AND OSELTAMIVIR IN TWO (2) LETHAL MODELS OF INFLUENZA A H5N1$3.7M
Aug 5, 2026Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95021F00001541715CHARACTERIZATION OF A NON-PARALYZING BONT-BASED BIOPHARMACEUTICAL FOR THE TREATMENT OF NEUROPATHIC PAIN$351K
Jul 17, 2026Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA75A50123F61001541714BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES$22K
Jun 23, 2026Department of DefenseDEFENSE HEALTH AGENCYW81XWH22P0157511210LICENSE AND MAINTENANCE SUPPORT, ON-SITE SUPPORT SERVICES FOR VSP WRAIR.$44K
Jun 22, 2026Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95023F00002541715EFFICACY AND SAFETY EVALUATION OF LEAD GENE THERAPY CANDIDATE IN NEUROMUSCULAR JUNCTION (NMJ) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT$303K
May 29, 2026Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95020F00001541712NON-CLINICAL SAFETY ASSESSMENT OF GENE THERAPY (PCCA, MMAB, DOK7 AND COLQ) TO SUPPORT PLATFORM GENE THERAPY FOR CONGENITAL MYASTHENIC DISEASES (DOK7, COLQ) AND ACIDEMIA (PCCA, MMAB)$1.3M
May 29, 2026Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95021F00002541715EFFICACY AND SAFETY EVALUATION OF A LEAD GENE THERAPY CANDIDATE IN METHYL MELANOMIC ACIDEMIA (MMAB) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT.$86K
May 7, 2026Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA75A50123F61001541714RADNUC 2201: PERFORMANCE VERIFICATION OF INSTITUTIONAL RADIATION DOSE RESPONSE FOR ACUTE RADIATION SYNDROME (ARS) ANIMAL MODELS (RODENT, RABBIT, MINIPIG, OR NON-HUMAN PRIMATE [NHP])$148K
Apr 1, 2026Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93022F00001541715THE CONTRACTOR SHALL PERFORM THE TRANSFER, VALIDATION AND QUALIFICATION OF BIOANALYTICAL METHODS FOR DETECTION OF CABOTEGRAVIR AND LEVONORGESTREL IN RAT AND NONHUMAN PRIMATE PLASMA$55K
Sep 30, 2025Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93025D00021541715EVALUATION AND TESTING SERVICES (ETS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES.$10K
Sep 22, 2025Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA75A50123F61001541714RADNUC 2201: PERFORMANCE VERIFICATION OF INSTITUTIONAL RADIATION DOSE RESPONSE FOR ACUTE RADIATION SYNDROME (ARS) ANIMAL MODELS (RODENT, RABBIT, MINIPIG, OR NON-HUMAN PRIMATE [NHP])$2.0M
Sep 19, 2025Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS75F40125P00216541380SOLE SOURCE AWARD OF A 24-MONTH PERIOD, FIRM FIXED PRICE (FFP), ENDS TOXICOLOGICAL STUDIES FOR CENTER FOR TOBACCO PRODUCTS (CTP).$7.1M
Aug 27, 2025Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93022F00001541715THE CONTRACTOR SHALL PERFORM THE TRANSFER, VALIDATION AND QUALIFICATION OF BIOANALYTICAL METHODS FOR DETECTION OF CABOTEGRAVIR AND LEVONORGESTREL IN RAT AND NONHUMAN PRIMATE PLASMA$139K
Jul 17, 2025Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA75A50123F61001541714BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES$21K
Jul 9, 2025Department of DefenseARMY MED RES ACQ ACTIVITYW81XWH22P0157511210LICENSE AND MAINTENANCE SUPPORT, ON-SITE SUPPORT SERVICES FOR VSP WRAIR.$42K
Jun 30, 2025Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS75F40119C10161541380STUDY OF E-CIGARETTE AEROSOL TOXICITY IN IN VIVO NONCLINICAL MODELS.$9.8M
May 19, 2025Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95020F00001541712NON-CLINICAL SAFETY ASSESSMENT OF GENE THERAPY (PCCA, MMAB, DOK7 AND COLQ) TO SUPPORT PLATFORM GENE THERAPY FOR CONGENITAL MYASTHENIC DISEASES (DOK7, COLQ) AND ACIDEMIA (PCCA, MMAB)$1.7M
Sep 20, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95020F00004541715CHARACTERIZATION OF A DOWNSTREAM GENE THERAPEUTIC FOR THE REPARATIVE TREATMENT OF SEVERE FRACTURES PERIOD OF PERFORMANCE SEPTEMBER 24, 2020 - NOVEMBER 23, 2021$133K
Sep 17, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95020F00002541715CHARACTERIZATION OF A NON-ADDICTIVE SMALL MOLECULE THERAPEUTICS FOR THE MANAGEMENT OF NON-CANCER PAIN PERIOD OF PERFORMANCE SEPTEMBER 18, 2020 - SEPTEMBER 17, 2022$121K
Aug 27, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NHLBI75N92024P0030354138024-015894 NHLBI POPULATION SCIENCES BRANCH REQUIRES PULMONARY FUNCTION TESTING TO DETERMINE IF THE FLEXIVENT METHOD OF PULMONARY FUNCTION TESTING IS SUITABLE TO BE USED IN A LARGER STUDY.$17K
Aug 19, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95020F00005541715EFFICACY AND SAFETY EVALUATION OF A LEAD GENE THERAPY CANDIDATE IN PROPIONIC ACIDEMIA (PA) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT. PERIOD OF PERFORMANCE SEPTEMBER 25, 2020 - SEPTEMBER 24, 2022$48K
Aug 14, 2024Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA75A50123F61001541714RADNUC 2201: PERFORMANCE VERIFICATION OF INSTITUTIONAL RADIATION DOSE RESPONSE FOR ACUTE RADIATION SYNDROME (ARS) ANIMAL MODELS (RODENT, RABBIT, MINIPIG, OR NON-HUMAN PRIMATE [NHP])$1.7M
Aug 6, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95024F00001541714KICK-OFF MEETING FOR THE PHARMACOLOGY STUDIES AND ANIMAL MODEL DEVELOPMENT AND RELATED SERVICES FOR DRUG DEVELOPMENT IDIQ CONTRACT.$1K
Aug 1, 2024Department of DefenseARMY MED RES ACQ ACTIVITYW81XWH22P0157511210LICENSE AND MAINTENANCE SUPPORT, ON-SITE SUPPORT SERVICES FOR VSP WRAIR.$225K
Jul 18, 2024Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA75A50123F61001541714BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES$37K
Jun 17, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95022F00001541715BIOANALYTICAL SUPPORTS FOR A GLP TOX/BIODISTRIBUTION STUDY IN MINI-PIGS$44K
Mar 20, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95024F00001541715EVALUATION OF POTENTIAL RESPIRATORY STIMULANT. TO4. PERIOD OF PERFORMANCE: MARCH 21, 2024 - MARCH 20, 2025.$141K
Mar 20, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95024F00002541715RESPIRATORY INTERACTION STUDIES IN RODENTS, ABILITY OF A TEST ARTICLE TO REVERSE THE RESPIRATORY DEPRESSANT EFFECTS OF OPIOIDS. TO5. PERIOD OF PERFORMANCE: MARCH 21, 2024 - MARCH 20, 2025.$211K
Jan 9, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95020F00005541715EFFICACY AND SAFETY EVALUATION OF A LEAD GENE THERAPY CANDIDATE IN PROPIONIC ACIDEMIA (PA) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT. PERIOD OF PERFORMANCE SEPTEMBER 25, 2020 - SEPTEMBER 24, 2022$3K
Dec 19, 2023Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NHLBI75N92024F00001541714GENE THERAPY RESOURCE PROGRAM (GTRP): PHARMACOLOGY AND TOXICOLOGY CORE LABORATORY - TASK AREA A: CORE ADMINISTRATIVE ACTIVITIES$11K
Nov 15, 2023Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95023F00001541715CHARACTERIZATION OF SPONTANEOUS OSTEOGENESIS AFTER SURGICAL SEGMENTAL BONE DEFECT IN A LARGE ANIMAL$192K
Sep 29, 2023Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS75F40123F19002541690TASK ORDER 2 - EXAMINING THE INFLUENCE OF SYNTHETIC COOLING AGENTS ON CIGARETTE SENSORY AND SUBJECTIVE EFFECTS AND USE BEHAVIOR$1.3M
Sep 29, 2023Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95023F00002541715EFFICACY AND SAFETY EVALUATION OF LEAD GENE THERAPY CANDIDATE IN NEUROMUSCULAR JUNCTION (NMJ) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT$1.6M
Sep 27, 2023Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA75A50123F61001541714RADNUC 2201: PERFORMANCE VERIFICATION OF INSTITUTIONAL RADIATION DOSE RESPONSE FOR ACUTE RADIATION SYNDROME (ARS) ANIMAL MODELS (RODENT, RABBIT, MINIPIG, OR NON-HUMAN PRIMATE [NHP])$2.0M
Sep 27, 2023Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS75F40123F19001541690TASK ORDER 1 -TITLE: ARE REDUCTIONS IN BOE, BOPH, AND OTHER HEALTH RISK MARKERS PROPORTIONAL TO REDUCTIONS IN CIGARETTE SMOKING UPON SWITCHING TO ENDS$3.9M
Sep 27, 2023Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95020F00005541715EFFICACY AND SAFETY EVALUATION OF A LEAD GENE THERAPY CANDIDATE IN PROPIONIC ACIDEMIA (PA) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT. PERIOD OF PERFORMANCE SEPTEMBER 25, 2020 - SEPTEMBER 24, 2022$380K
Sep 26, 2023Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS75F40123D00039541690AWARD OF FIVE-YEAR IDIQ FOR CTP- ASSESSING TOBACCO-RELATED CLINICAL OUTCOMES AND HUMAN BEHAVIORS IN TOBACCO$5K
Sep 22, 2023Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NHLBI75N92023F00001541714GENE THERAPY RESOURCE PROGRAM (GTRP): PHARMACOLOGY AND TOXICOLOGY CORE LABORATORY$234K
Sep 19, 2023Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95020F00003541715NATURAL HISTORY STUDIES IN NEUROMUSCULAR JUNCTION (NMJ) DISEASE MOUSE MODELS. PERIOD OF PERFORMANCE SEPTEMBER 28, 2020 - DECEMBER 31, 2021$17K
Sep 11, 2023Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NHLBI75N92023P00366541380EVALUATION OF AN ASO IN THE MOUSE CIGARETTE SMOKE AND INFLUENZA MODEL$171K
Aug 29, 2023Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS75F40122F19001541690CTP-2022-111127 - SALTS$53K
Aug 28, 2023Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95021F00001541715CHARACTERIZATION OF A NON-PARALYZING BONT-BASED BIOPHARMACEUTICAL FOR THE TREATMENT OF NEUROPATHIC PAIN$128K
Aug 25, 2023Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95020F00002541715CHARACTERIZATION OF A NON-ADDICTIVE SMALL MOLECULE THERAPEUTICS FOR THE MANAGEMENT OF NON-CANCER PAIN PERIOD OF PERFORMANCE SEPTEMBER 18, 2020 - SEPTEMBER 17, 2022$169K
Aug 25, 2023Department of DefenseW4PZ USA MED RSCH ACQUIS ACTW81XWH22P0157511210LICENSE AND MAINTENANCE SUPPORT, ON-SITE SUPPORT SERVICES FOR VSP WRAIR.$219K
Aug 3, 2023Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95023F00001541715CHARACTERIZATION OF SPONTANEOUS OSTEOGENESIS AFTER SURGICAL SEGMENTAL BONE DEFECT IN A LARGE ANIMAL$194K
Aug 2, 2023Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA75A50123F61001541714BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES$20K
Jun 28, 2023Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93023F00001541715GUARANTEED MINIMUM$18K
Apr 5, 2023Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93023F00001541715GUARANTEED MINIMUM$3K

Get Alerted Before Lovelace Biomedical Research Institute's Next Recompete

Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.

Start for free